ProQR Therapeutics BV (PRQR)

ProQR Therapeutics BV (PRQR) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $195M; returns 1 day -3.0%, 1 week -1.5%, 1 year -54.3%.

ProQR Therapeutics N.V. (PRQR) is a biotechnology company based in Leiden, the Netherlands, dedicated to developing RNA therapies for severe rare and common diseases. The company's core technology is its proprietary Axiomer™ RNA editing platform, which leverages the cell's naturally occurring ADAR (Adenosine Deaminase Acting on RNA) machinery to make specific, single nucleotide changes in RNA.

Groups PRQR belongs to

• Biotechnology
• Life Sciences
• Clinical Stage Biotech
• Healthcare
• Clinical Stage
• Rare Diseases
• Biopharmaceutical
• Strategic Partnerships

PRQR financial model: income statement, cash flow and balance sheet